Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis

por Luo, Yi, Decato, Benjamin E., Charles, Edgar D., Shevell, Diane E., McNaney, Colleen, Shipkova, Petia, Apfel, Abraham, Tirucherai, Giridhar S., Sanyal, Arun J.
Publicado 2021

Determining a healthy reference range and factors potentially influencing PRO-C3 – A biomarker of liver fibrosis

por Erhardtsen, Elisabeth, Rasmussen, Daniel G.K., Frederiksen, Peder, Leeming, Diana Julie, Shevell, Diane, Gluud, Lise Lotte, Karsdal, Morten Asser, Aithal, Guruprasad P., Schattenberg, Jörn M.
Publicado 2021

Pharmacokinetic, Pharmacodynamic, and Safety Profile of a Novel Anti‐CD28 Domain Antibody Antagonist in Healthy Subjects

por Shi, Rong, Honczarenko, Marek, Zhang, Sean, Fleener, Catherine, Mora, Johanna, Lee, Sun Ku, Wang, Reena, Liu, Xiaoni, Shevell, Diane E., Yang, Zheng, Wang, Haiqing, Murthy, Bindu
Publicado 2016

SOMAscan Proteomics Identifies Serum Biomarkers Associated With Liver Fibrosis in Patients With NASH

por Luo, Yi, Wadhawan, Samir, Greenfield, Alex, Decato, Benjamin E., Oseini, Abdul M., Collen, Rebecca, Shevell, Diane E., Thompson, John, Jarai, Gabor, Charles, Edgar D., Sanyal, Arun J.
Publicado 2021

BMS‐986263 in patients with advanced hepatic fibrosis: 36‐week results from a randomized, placebo‐controlled phase 2 trial

por Lawitz, Eric J., Shevell, Diane E., Tirucherai, Giridhar S., Du, Shuyan, Chen, Warner, Kavita, Uma, Coste, Angie, Poordad, Fred, Karsdal, Morten, Nielsen, Mette, Goodman, Zachary, Charles, Edgar D.
Publicado 2021

Urinary CD80 Discriminates Among Glomerular Disease Types and Reflects Disease Activity

por Gonzalez Guerrico, Anatilde M., Lieske, John, Klee, George, Kumar, Sanjay, Lopez-Baez, Victor, Wright, Adam M., Bobart, Shane, Shevell, Diane, Maldonado, Michael, Troost, Jonathan P., Hogan, Marie C.
Publicado 2020

Population Pharmacokinetic Analysis of BMS‐986166, a Novel Selective Sphingosine‐1‐Phosphate‐1 Receptor Modulator, and Exposure‐Response Assessment of Lymphocyte Counts and Heart R...

por Bihorel, Sébastien, Singhal, Shalabh, Shevell, Diane, Sun, Huadong, Xie, Jenny, Basdeo, Shenita, Liu, Ang, Dutta, Santanu, Ludwig, Elizabeth, Huang, Hannah, Lin, Kuan‐ju, Fura, Aberra, Throup, John, Girgis, Ihab G.
Publicado 2020

PRO‐C3, a Serological Marker of Fibrosis, During Childhood and Correlations With Fibrosis in Pediatric NAFLD

por Cohen, Catherine C., Castillo‐Leon, Eduardo, Farris, Alton B., Caltharp, Shelley A., Cleeton, Rebecca L., Sinclair, Elizabeth M., Shevell, Diane E., Karsdal, Morten A., Nielsen, Mette Juul Fisker, Leeming, Diana J., Vos, Miriam B.
Publicado 2021

Discovery and Clinical Evaluation of MK‐8150, A Novel Nitric Oxide Donor With a Unique Mechanism of Nitric Oxide Release

por Knox, Clayton D., de Kam, Pieter‐Jan, Azer, Karim, Wong, Peggy, Ederveen, Antwan G., Shevell, Diane, Morabito, Christopher, Meehan, Alan G., Liu, Wen, Reynders, Tom, Denef, Jean Francois, Mitselos, Anna, Jonathan, Daniel, Gutstein, David E., Mitra, Kaushik, Sun, Shu Yu, Lo, Michael Man‐Chu, Cully, Doris, Ali, Amjad
Publicado 2016